~~<i id='3B7A3EC2A2'><strike id='3B7A3EC2A2'><tt id='3B7A3EC2A2'><pre id='3B7A3EC2A2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：comprehensive 2025-09-29 19:57:38 - browse：2

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： States should stop sabotaging methadone treatment reform

hotspot

Wikipedia

leisure time

focus

explore

leisure time

AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona

WSS

States should stop sabotaging methadone treatment reform

The nurse manager staffing crisis is hurting patients

Vertex Pharmaceuticals may move headquarters in Boston

Patient advocates debate FDA's accelerated approval process

The nurse manager staffing crisis is hurting patients

As JPM 2024 winds down, some health tech firms project optimism

entertainment

leisure time

hotspot

Continuity nursing helped my family in our darkest PICU moments

The Readout: Lenmeldy, GLP

Hollywood unions extend contract negotiations for actors

Risky weight loss products often used by teens globally, per study

Guidelines to prevent youth baseball injuries need more muscle

Eliminate the waiting period for sterilization covered by Medicaid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

States should stop sabotaging methadone treatment reform

New air purifier tech could be key to improving indoor air quality

Patient advocates debate FDA's accelerated approval process

Wikipedia

Food as medicine: Medically tailored meals may get standardized

New Medicare drug pricing powers could soon be upended in court

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

States should stop sabotaging methadone treatment reform

How I ended up pumping milk in a bathroom stall at JPM 2024

JPM 2024: Verve Therapeutics looks to mainstream genome editing

leisure time

focus

explore

leisure time